Study in Patients With Asthma
Primary Purpose
Asthma
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Formoterol Fumarate
Sponsored by

About this trial
This is an interventional treatment trial for Asthma focused on measuring Asthma, Formoterol, Fumarate
Eligibility Criteria
Inclusion Criteria: Patients with a history of asthma Exclusion Criteria: Current asthma exacerbation or recent asthma exacerbation, requiring hospitalization History of smoking Debilitating systemic and/or life-threatening diseases.
Sites / Locations
- Research Site
- Research Site
- Research Site
Outcomes
Primary Outcome Measures
The primary outcome variable is the measure of lung function.
Secondary Outcome Measures
Secondary outcomes include change in lung function, as well as in vital signs.
Physical exams, AE reporting, etc.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00215397
Brief Title
Study in Patients With Asthma
Study Type
Interventional
2. Study Status
Record Verification Date
February 2008
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
February 2003 (Actual)
Study Completion Date
December 2005 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Dey
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to determine which dose of the investigational drug is the most safe and effective in the treatment of asthma compared to the control drug.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma
Keywords
Asthma, Formoterol, Fumarate
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
Double
Allocation
Randomized
Enrollment
16 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Formoterol Fumarate
Primary Outcome Measure Information:
Title
The primary outcome variable is the measure of lung function.
Secondary Outcome Measure Information:
Title
Secondary outcomes include change in lung function, as well as in vital signs.
Title
Physical exams, AE reporting, etc.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with a history of asthma
Exclusion Criteria:
Current asthma exacerbation or recent asthma exacerbation, requiring hospitalization
History of smoking
Debilitating systemic and/or life-threatening diseases.
Facility Information:
Facility Name
Research Site
City
Long Beach
State/Province
California
ZIP/Postal Code
90806
Country
United States
Facility Name
Research Site
City
Denver
State/Province
Colorado
ZIP/Postal Code
80206
Country
United States
Facility Name
Research Site
City
Medford
State/Province
Oregon
ZIP/Postal Code
97504
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Study in Patients With Asthma
We'll reach out to this number within 24 hrs